Clinical Trials Directory

Trials / Completed

CompletedNCT04158986

Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis

Post-discharge Nurse-driven Intervention Program for Patients With Decompensated Liver Cirrhosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Copenhagen University Hospital, Hvidovre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In a randomized controlled trial, the effects of a nurse-driven post-discharge intervention for patients with liver cirrhosis compared with standard follow-up will be investigated.

Detailed description

Since 1970 the mortality from cirrhosis has increased with 26.7 %, with a 50% mortality rate within 2 years of diagnosis. Grave complications result in functional impairment and reduced quality of life. 20-37 % of patients with liver cirrhosis are readmitted less than 30 days after a hospitalization for decompensation. These patients have a higher 90-day mortality rate than those who avoid readmission. Re-admissions have great personal-, societal- and economic consequences. In a randomized controlled trial, the effects of a nurse-driven post-discharge intervention for patients with liver cirrhosis, compared with standard follow-up will be investigated. The intervention, based on concepts from Family Nursing, will comprise three home-visits within eight weeks after discharge including therapeutic conversations focusing on strengthening participants' family relationships and social networks, disease education and help to initiate contact to municipal offers. After 12 weeks the participants will be followed-up by telephone.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNurse-driven post-discharge interventionHome visits based on the concepts of Family Nursing: The participants will receive three home visits by a nurse who is trained in the Family Nursing principles during the first 12 weeks after discharge. The home visits will comprise of: * Filling in the Chronic Liver Disease Questionnaire. * Therapeutic conversations including drawing and review of genogram and eco-map. * Information about- and help to initiate contact to relevant municipal offers. * Evidence-based information based on the patient's current problems or symptoms, base-line knowledge and receptiveness. Follow-up telephone calls: • After the first 12 weeks participants will be followed-up by telephone monthly during the following 12 weeks. Pamphlet: • All participants will receive a pamphlet with brief information regarding preventive measures and early signs of decompensation as well as relevant contact details. The pamphlet will be handed out before discharge

Timeline

Start date
2019-12-01
Primary completion
2021-10-13
Completion
2022-10-01
First posted
2019-11-12
Last updated
2022-12-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04158986. Inclusion in this directory is not an endorsement.